Choi Kwang-Ho, Clements Robert L H, Greenshaw Andrew J
Department of Psychiatry, NC6.524 University of Texas, Southwestern Medical Center, Dallas, TX 75390-9070, USA.
Behav Brain Res. 2005 Mar 7;158(1):79-88. doi: 10.1016/j.bbr.2004.08.010.
Interactions between dopamine (DA) and glutamate (GLU) in the mesocorticolimbic pathway of the brain may influence motivation and reward. Previous work from this laboratory has demonstrated that alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA)/kainate receptor blockade may potentiate decreases in exploratory motor activity induced by the DA D(2/3) receptor agonist 7-OH-DPAT in the nucleus accumbens septi (NAS). This study investigated the interaction of AMPA/kainate receptor antagonists CNQX or NBQX with 7-OH-DPAT on ventral tegmental area (VTA) brain stimulation reward (BSR). Effects of these compounds, alone and combined, were measured in male Sprague-Dawley rats stereotaxically implanted with a unilateral VTA electrode and bilateral guide cannulae in the NAS core or shell subregions. Rate-frequency analysis was used to assess BSR frequency thresholds and maximum response rates of rats trained to lever-press for reinforcing electrical stimulation. When given alone, CNQX (0.5 microg), NBQX (0.5 microg), or 7-OH-DPAT (5.0 microg) did not affect BSR frequency thresholds. Co-administration of CNQX or NBQX with 7-OH-DPAT synergistically increased BSR frequency thresholds, indicative of decreased reward. These data indicate that simultaneous AMPA/kainate receptor blockade and DA D(2/3) receptor stimulation in the NAS may act synergistically to inhibit motivated behaviours such as electrical brain self-stimulation.
大脑中脑皮质边缘通路中多巴胺(DA)与谷氨酸(GLU)之间的相互作用可能会影响动机和奖赏。该实验室之前的研究表明,α-氨基-3-羟基-5-甲基异恶唑-4-丙酸(AMPA)/海人藻酸受体阻断可能会增强伏隔核(NAS)中DA D(2/3)受体激动剂7-羟基-DPAT诱导的探索性运动活动的减少。本研究调查了AMPA/海人藻酸受体拮抗剂CNQX或NBQX与7-羟基-DPAT对腹侧被盖区(VTA)脑刺激奖赏(BSR)的相互作用。在立体定位植入单侧VTA电极和NAS核心或壳亚区双侧引导套管的雄性Sprague-Dawley大鼠中测量了这些化合物单独及联合使用的效果。速率-频率分析用于评估接受杠杆按压训练以强化电刺激的大鼠的BSR频率阈值和最大反应率。单独给予时,CNQX(0.5微克)、NBQX(0.5微克)或7-羟基-DPAT(5.0微克)不影响BSR频率阈值。CNQX或NBQX与7-羟基-DPAT共同给药可协同提高BSR频率阈值,表明奖赏降低。这些数据表明,在NAS中同时进行AMPA/海人藻酸受体阻断和DA D(2/3)受体刺激可能会协同作用,抑制诸如脑电自我刺激等动机行为。